Regenerative Medicine Market

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body?s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.

Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and ?the vanguard of 21st century healthcare? by the U.S. Department of Health and Human Services.

Regenerative Medicine Market contains market size and forecasts of Regenerative Medicine in Global, including the following market information:

Global Regenerative Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Regenerative Medicine market was valued at 34340 million in 2021 and is projected to reach US$ 111830 million by 2028, at a CAGR of 18.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Regenerative Medicine include J & J (DePuy Synthes), Medtronic, Zimmer Biomet, Stryker, Allergan(Acelity), MiMedx Group, Organogenesis, Fujifilm Cellular Dynamics and Osiris Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Regenerative Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Regenerative Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Regenerative Medicine Market Segment Percentages, by Type, 2021 (%)

Cell Therapy

Tissue Engineering

Biomaterial

Other

Global Regenerative Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Regenerative Medicine Market Segment Percentages, by Application, 2021 (%)

Dermatology

Cardiovascular

CNS

Orthopedic

Others

Global Regenerative Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Regenerative Medicine Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Regenerative Medicine revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Regenerative Medicine revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

J & J (DePuy Synthes)

Medtronic

Zimmer Biomet

Stryker

Allergan(Acelity)

MiMedx Group

Organogenesis

Fujifilm Cellular Dynamics

Osiris Therapeutics

Vcanbio

CCBC

Cytori

Celgene

Vericel Corporation

Guanhao Biotech

Mesoblast

AMAG Pharmaceuticals (CBR)

ViaCord

CordLife

Integra LifeSciences

Nuvasive

Cook Biotech

Japan Tissue Engineering